Rocket Pharmaceuticals Presents Clinical Data from RP-A501 Trial in Danon Disease at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2021 | BioSpace

Gene therapy for Danon Disease

Read the full article here

Related Articles